Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes
Infectious complications are an important cause of morbidity and mortality in patients with
myelodysplastic syndromes (MDS). Preventing infections could significantly improve both …
myelodysplastic syndromes (MDS). Preventing infections could significantly improve both …
Health-related quality of life as assessed by the EQ-5D-5L predicts outcomes of patients treated with azacitidine—a prospective cohort study by the AGMT
L Pleyer, S Heibl, C Tinchon, S Vallet, M Schreder… - Cancers, 2023 - mdpi.com
Simple Summary The EuroQol 5-Dimension 5-level (EQ-5D-5L) questionnaire is a globally
used and multiply validated tool to assess health-related quality of life (HRQoL), but data on …
used and multiply validated tool to assess health-related quality of life (HRQoL), but data on …
Association between serum albumin and 60-day mortality in Chinese Hakka patients with non-APL acute myeloid leukemia: a retrospective cohort study
Z Xiao, H Li, D Xiao, Y Liu, X Chen, S Luo, Y Ji - BMC cancer, 2022 - Springer
Background Acute myeloid leukemia (AML) is the main type of adult leukemia, and 60-day
mortality is a vital clinical problem that doctors have to face at the begin with treatment …
mortality is a vital clinical problem that doctors have to face at the begin with treatment …
Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system
H Okamoto, Y Inoue, A Miyashita… - International Journal of …, 2023 - Springer
The prognostic impact of patient-related factors, including age, nutritional parameters, and
inflammation status, in higher-risk myelodysplastic syndromes (HR-MDS) has been largely …
inflammation status, in higher-risk myelodysplastic syndromes (HR-MDS) has been largely …
Therapeutic options in high-risk myelodysplastic syndrome
M Maksymowicz, S Moqbil… - … in Clinical Practice, 2022 - journals.viamedica.pl
Myelodysplastic syndromes (MDS) constitute a heterogeneous group of diseases
characterised by ineffective haematopoiesis, dysplasia and cytopenias. The treatment for …
characterised by ineffective haematopoiesis, dysplasia and cytopenias. The treatment for …